Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu 
American Aires Inc. Announces Change of Auditor 
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation 
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units 
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award Northstar Capital Invests in Standard Locknut, LLC
MINNEAPOLIS–(BUSINESS WIRE)–Northstar Capital (“Northstar”), a provider of junior capital for middle market private equity transactions,…
Frame AI Raises $7.6 Million for its AI-Driven Customer Intelligence Platform
Funding Led by G20 Ventures with New Participation from Velvet Sea, ValueStream, Twilio and LiveRamp…
Kristen A. Johnson Promoted to Senior Vice President and Chief Administrative Officer of SJW Group
SAN JOSE, Calif.–(BUSINESS WIRE)–SJW Group (NYSE: SJW) has announced that Kristen A. Johnson has been…
Telstra Taps Katy Greenfield to Lead Customer Solutions for the Americas
Experienced technology operations and sales leader to drive Telstra’s development of market-focused network connectivity technologies…
Samsung Innovation Campus AI Course Empowers Communities through Education
Samsung Innovation Campus is kicking off its second year in the U.S. to strengthen future…
Granulate Announces Support for AWS for Advertising & Marketing Initiative
TEL AVIV, Israel–(BUSINESS WIRE)–Granulate, an Intel Company and developer of autonomous, continuous workload optimization solutions,…
HGS Launches Global Customer Experience Hub in Barranquilla, Colombia To Support Multilingual Customer Experience Needs
Career opportunities for leadership, HR, training, and frontline customer advocates CHICAGO & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Hinduja…
Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results
HAMILTON, BERMUDA, Nov. 30, 2022 (GLOBE NEWSWIRE) — BentrioTM nasal spray launched in Hong Kong…
Acer Therapeutics Announces $1.5M Private Placement
NEWTON, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
SCYNEXIS Announces $3 Million National Institutes of Health Grant Has Been Awarded to Case Western Reserve University Researchers to Study Second Generation Fungerp (SCY-247) to Fight Drug-Resistant Fungi
Researchers to study the potential of SCY-247 to fight Candida auris (C.auris), a multidrug-resistant pathogen…
SELLAS Life Sciences to Participate in the JMP Securities Hematology and Oncology Summit
NEW YORK, Nov. 30, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Reimbursed Access to Bylvay® (odevixibat) Approved in France for Patients with PFIC 1 & 2
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company…
Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma
Hamilton, Bermuda, Nov. 30, 2022 (GLOBE NEWSWIRE) — Initiative is Nuance’s first step in penetrating…
Cerevance Announces Presentation of Preclinical Data During the Cold Spring Harbor Laboratory (CSHL) Neurodegenerative Diseases – Biology and Therapeutics Conference and Publication in Neuropharmacology
Presentation highlights a novel target identified for Alzheimer’s disease using Cerevance’s proprietary NETSseq platform Cerevance’s…
Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials
AGOURA HILLS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Agios to Participate in December Investor Conference
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pierre Fabre to Evaluate ERAS-007 and Encorafenib Combination
ERAS-007, a potential best-in-class ERK1/2 inhibitor, is being evaluated in combination with encorafenib and cetuximab…
Centessa Pharmaceuticals Announces New Chief People Officer Karen Anderson
BOSTON and LONDON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company…
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development Data presented at CTAD 2022…